BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar V, Vashishta M, Kong L, Wu X, Lu JJ, Guha C, Dwarakanath BS. The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies. Front Cell Dev Biol 2021;9:650772. [PMID: 33968932 DOI: 10.3389/fcell.2021.650772] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Farzaneh M, Najafi S, Sheykhi-Sabzehpoush M, Nezhad Dehbashi F, Anbiyaee O, Nasrolahi A, Azizidoost S. The stem cell-specific long non-coding RNAs in leukemia. Clin Transl Oncol 2023;25:345-51. [PMID: 36168086 DOI: 10.1007/s12094-022-02952-2] [Reference Citation Analysis]
2 Corrigal JC, Zaka M, Myssina S, Michaelis M, Cinatl J, Ahmed S, Carr-wilkinson J. Stem cell pathways and Notch signaling an emerging role in the development of acquired Drug Resistance in Neuroblastoma.. [DOI: 10.21203/rs.3.rs-2471355/v1] [Reference Citation Analysis]
3 Zhang Z, Wang G, Zhong K, Chen Y, Yang N, Lu Q, Yuan B, Wang Z, Li H, Guo L, Zhang R, Wu Z, Zheng M, Zhao S, Tang X, Shao B, Tong A. A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacy. J Transl Med 2023;21:23. [PMID: 36635683 DOI: 10.1186/s12967-023-03875-4] [Reference Citation Analysis]
4 Bosze B, Suarez-Navarro J, Cajias I, Brzezinski JA, Brown NL. Not all Notch pathway mutations are equal in the embryonic mouse retina. bioRxiv 2023:2023. [PMID: 36711950 DOI: 10.1101/2023.01.11.523641] [Reference Citation Analysis]
5 Thalheim T, Aust G, Galle J. Organoid Cultures In Silico: Tools or Toys? Bioengineering (Basel) 2022;10. [PMID: 36671623 DOI: 10.3390/bioengineering10010050] [Reference Citation Analysis]
6 Ruolan Xia, Maosen Xu, Jing Yang, Xuelei Ma. The role of Hedgehog and Notch signaling pathway in cancer. Mol Biomed 2022;3:44. [PMID: 36517618 DOI: 10.1186/s43556-022-00099-8] [Reference Citation Analysis]
7 Tang L, Spezia M, Chen T, Shin J, Wang F, Stappenbeck F, Lebensohn AM, Parhami F, Zhang YE. Oxysterol derivatives Oxy186 and Oxy210 inhibit WNT signaling in non-small cell lung cancer. Cell Biosci 2022;12:119. [DOI: 10.1186/s13578-022-00857-9] [Reference Citation Analysis]
8 Sharma U, Tuli HS, Uttam V, Choudhary R, Sharma B, Sharma U, Prakash H, Jain A. Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs. Pharmacological Research 2022;186:106523. [DOI: 10.1016/j.phrs.2022.106523] [Reference Citation Analysis]
9 Ostojić M, Đurić A, Živić K, Grahovac J. Pan-cancer analysis reveals that nischarin may not be the universal tumor suppressor.. [DOI: 10.21203/rs.3.rs-2288348/v1] [Reference Citation Analysis]
10 Martínez-Sifuentes MA, Bassol-Mayagoitia S, Nava-Hernández MP, Ruiz-Flores P, Ramos-Treviño J, Haro-Santa Cruz J, Hernández-Ibarra JA. Survivin in Breast Cancer: A Review. Genet Test Mol Biomarkers 2022;26:411-21. [PMID: 36166738 DOI: 10.1089/gtmb.2021.0286] [Reference Citation Analysis]
11 Arutyunyan IV, Soboleva AG, Gordon KB, Kudashkina DS, Miroshnichenko DA, Polyakov AP, Rebrikova IV, Makarov AV, Lokhonina AV, Fatkhudinov TK. Differential Markers of Subpopulations of Epithelial Cells of the Larynx in Squamous Cell Carcinoma. Bull Exp Biol Med 2022;173:553-559. [DOI: 10.1007/s10517-022-05588-y] [Reference Citation Analysis]
12 Huang J, Huo H, Lu R. A Novel Signature of Necroptosis-Associated Genes as a Potential Prognostic Tool for Head and Neck Squamous Cell Carcinoma. Front Genet 2022;13:907985. [PMID: 35754840 DOI: 10.3389/fgene.2022.907985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 De Francesco EM, Cirillo F, Vella V, Belfiore A, Maggiolini M, Lappano R. Triple-negative breast cancer drug resistance, durable efficacy, and cure: How advanced biological insights and emerging drug modalities could transform progress. Expert Opin Ther Targets 2022. [PMID: 35761781 DOI: 10.1080/14728222.2022.2094762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Therachiyil L, Krishnankutty R, Ahmad F, Mateo JM, Uddin S, Korashy HM. Aryl Hydrocarbon Receptor Promotes Cell Growth, Stemness Like Characteristics, and Metastasis in Human Ovarian Cancer via Activation of PI3K/Akt, β-Catenin, and Epithelial to Mesenchymal Transition Pathways. Int J Mol Sci 2022;23:6395. [PMID: 35742838 DOI: 10.3390/ijms23126395] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Zhai Y, Shan C, Zhang H, Kong P, Zhang L, Wang Y, Hu X, Cheng X. FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma. Mol Cell Biochem 2022. [PMID: 35606602 DOI: 10.1007/s11010-022-04475-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Byerly CD, Mitra S, Patterson LL, Pittner NA, Velayutham TS, Paessler S, Veljkovic V, Mcbride JW. Ehrlichia SLiM ligand mimetic activates Hedgehog signaling to engage a BCL-2 anti-apoptotic cellular program. PLoS Pathog 2022;18:e1010345. [DOI: 10.1371/journal.ppat.1010345] [Reference Citation Analysis]
17 Roy Acharyya S, Sen P, Kandasamy T, Sankar Ghosh S. Dual therapeutic approach to modulate Glycogen Synthase kinase −3 beta (GSK-3Β) and inhibitor of nuclear factor kappa kinase-beta (IKK-β) receptors by in silico designing of inhibitors. Journal of Molecular Graphics and Modelling 2022. [DOI: 10.1016/j.jmgm.2022.108225] [Reference Citation Analysis]
18 Rodriguez SMB, Staicu GA, Sevastre AS, Baloi C, Ciubotaru V, Dricu A, Tataranu LG. Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer. Int J Mol Sci 2022;23:4602. [PMID: 35562993 DOI: 10.3390/ijms23094602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Yang B, Zhang B, Zhao Q, Li J, Shi Y. Development of New Thiophene-Containing Triaryl Pyrazoline Derivatives as PI3Kγ Inhibitors. Molecules 2022;27:2404. [DOI: 10.3390/molecules27082404] [Reference Citation Analysis]
20 Alamilla-Presuel JC, Burgos-Molina AM, González-Vidal A, Sendra-Portero F, Ruiz-Gómez MJ. Factors and molecular mechanisms of radiation resistance in cancer cells. Int J Radiat Biol 2022;:1-45. [PMID: 35225732 DOI: 10.1080/09553002.2022.2047825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, Chrystel I, Morandi U, Stella F, Dominici M, Haider KH. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers (Basel) 2022;14:976. [PMID: 35205721 DOI: 10.3390/cancers14040976] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
22 Byerly CD, Mitra S, Patterson LL, Pittner NA, Velayutham TS, Paessler S, Veljkovic V, Mcbride JW. Ehrlichia SLiM ligand mimetic activates Hedgehog signaling to engage a BCL-2 anti-apoptotic cellular program.. [DOI: 10.1101/2022.02.08.479502] [Reference Citation Analysis]
23 Guo R, Xing QS. Roles of Wnt Signaling Pathway and ROR2 Receptor in Embryonic Development: An Update Review Article. Genet Epigenet 2022;15:251686572110642. [DOI: 10.1177/25168657211064232] [Reference Citation Analysis]
24 Shih PC. The role of the STAT3 signaling transduction pathways in radioresistance. Pharmacol Ther 2022;234:108118. [PMID: 35085605 DOI: 10.1016/j.pharmthera.2022.108118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Casati G, Giunti L, Iorio AL, Marturano A, Galli L, Sardi I. Hippo Pathway in Regulating Drug Resistance of Glioblastoma. IJMS 2021;22:13431. [DOI: 10.3390/ijms222413431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Shi LZ, Bonner JA. Bridging Radiotherapy to Immunotherapy: The IFN-JAK-STAT Axis. Int J Mol Sci 2021;22:12295. [PMID: 34830176 DOI: 10.3390/ijms222212295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Spitzner M, Emons G, Schütz KB, Wolff HA, Rieken S, Ghadimi BM, Schneider G, Grade M. Inhibition of Wnt/β-Catenin Signaling Sensitizes Esophageal Cancer Cells to Chemoradiotherapy. Int J Mol Sci 2021;22:10301. [PMID: 34638639 DOI: 10.3390/ijms221910301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhao M, Sun B, Wang Y, Qu G, Yang H, Wang P. miR-27-3p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to the Antitumor Agent Olaparib by Targeting PSEN-1, the Catalytic Subunit of Γ-Secretase. Front Oncol 2021;11:694491. [PMID: 34169001 DOI: 10.3389/fonc.2021.694491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]